EP Patent

EP0204285A1 — Imidazoheterocyclic compounds processes for preparation thereof and pharmaceutical compositions comprising them

Assigned to Fujisawa Pharmaceutical Co Ltd · Expires 1986-12-10 · 39y expired

What this patent protects

Imidazoheterocyclic compounds of the formula: <CHEM> wherein R<1> is lower alkenyl, lower alkynyl, lower alkadienyl, lower alkenyloxy (lower) alkyl, lower alkynyloxy(lower)alkyl, carboxy(lower)alkynyloxy(loweralkyl or protected carboxy(lower)alkynyloxy(lower)alkyl, …

USPTO Abstract

Imidazoheterocyclic compounds of the formula: <CHEM> wherein R<1> is lower alkenyl, lower alkynyl, lower alkadienyl, lower alkenyloxy (lower) alkyl, lower alkynyloxy(lower)alkyl, carboxy(lower)alkynyloxy(loweralkyl or protected carboxy(lower)alkynyloxy(lower)alkyl, R<2> is hydrogen, lower alkyl or aryl, R<3> is ar(lower)alkyl which may have one or more suitable substituent(s), ar(lower)alkenyl, condensed bicyclic hydrocarbon group, lower alkyl having cyclo(lower)alkyl or lower alkyl, X is O or NH, and Y is CH or N and a pharmaceutical acceptable salt thereof, processes for their preparation and pharmaceutical compositions comprising them as an active ingredient.

Drugs covered by this patent

Patent Metadata

Patent number
EP0204285A1
Jurisdiction
EP
Classification
Expires
1986-12-10
Drug substance claim
No
Drug product claim
No
Assignee
Fujisawa Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.